Direct Restriction of Virus Release and Incorporation of the Interferon-Induced Protein BST-2 into HIV-1 Particles
暂无分享,去创建一个
[1] Marc C. Johnson,et al. Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells , 2009, Cell.
[2] S. Neil,et al. Antagonism to and Intracellular Sequestration of Human Tetherin by the Human Immunodeficiency Virus Type 2 Envelope Glycoprotein , 2009, Journal of Virology.
[3] A. Sakurai,et al. Dimerization of Tetherin Is Not Essential for Its Antiviral Activity against Lassa and Marburg Viruses , 2009, PloS one.
[4] K. Strebel,et al. The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu , 2009, Retrovirology.
[5] L. Lanier,et al. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction , 2009, The Journal of experimental medicine.
[6] R. Benarous,et al. Vpu Antagonizes BST-2–Mediated Restriction of HIV-1 Release via β-TrCP and Endo-Lysosomal Trafficking , 2009, PLoS pathogens.
[7] S. Westmoreland,et al. Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2 , 2009, PLoS pathogens.
[8] H. Kräusslich,et al. HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. , 2009, Cell host & microbe.
[9] P. Bates,et al. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein , 2009, Proceedings of the National Academy of Sciences.
[10] K. Strebel,et al. Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion , 2009, Proceedings of the National Academy of Sciences.
[11] T. Noda,et al. Inhibition of Lassa and Marburg Virus Production by Tetherin , 2008, Journal of Virology.
[12] P. Bieniasz,et al. Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin , 2008, Journal of Virology.
[13] Michael Emerman,et al. HIV-1 accessory proteins--ensuring viral survival in a hostile environment. , 2008, Cell host & microbe.
[14] Marc C. Johnson,et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. , 2008, Cell host & microbe.
[15] P. Bieniasz,et al. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu , 2008, Nature.
[16] D. Richman,et al. A computer-based, image-analysis method to quantify HIV-1 infection in a single-cycle infectious center assay. , 2006, Journal of virological methods.
[17] A. McCormack,et al. Quantitative Membrane Proteomics Reveals New Cellular Targets of Viral Immune Modulators , 2006, PLoS pathogens.
[18] R. Schreiber,et al. Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation1 , 2006, The Journal of Immunology.
[19] Mark H Ellisman,et al. Transform-based backprojection for volume reconstruction of large format electron microscope tilt series. , 2006, Journal of structural biology.
[20] P. Bieniasz,et al. HIV-1 Vpu Promotes Release and Prevents Endocytosis of Nascent Retrovirus Particles from the Plasma Membrane , 2006, PLoS pathogens.
[21] Toshio Matsumoto,et al. Antitumor activity of humanized monoclonal antibody against HM1.24 antigen in human myeloma xenograft models. , 2006, Oncology reports.
[22] Thomas J Deerinck,et al. Correlated light and electron microscopic imaging of multiple endogenous proteins using Quantum dots , 2005, Nature Methods.
[23] J. Petriz,et al. Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry. , 2005, Cellular immunology.
[24] G. Ruthel,et al. In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Spearman,et al. Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[26] George Banting,et al. Bst‐2/HM1.24 Is a Raft‐Associated Apical Membrane Protein with an Unusual Topology , 2003, Traffic.
[27] J. Lifson,et al. Differential Incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and Major Histocompatibility Complex Class I and II Molecules into Human Immunodeficiency Virus Type 1 Virions and Microvesicles: Implications for Viral Pathogenesis and Immune Regulation , 2001, Journal of Virology.
[28] Dzung H. Nguyen,et al. Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts , 2000, Journal of Virology.
[29] M. Tsuchiya,et al. Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. , 1999, Biochemical and biophysical research communications.
[30] U. Schubert,et al. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains , 1996, Journal of virology.
[31] J R Kremer,et al. Computer visualization of three-dimensional image data using IMOD. , 1996, Journal of structural biology.
[32] P. Charneau,et al. Fusion from without directed by human immunodeficiency virus particles , 1994, Journal of virology.
[33] R. Orentas,et al. Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. , 1993, AIDS research and human retroviruses.
[34] T. Klimkait,et al. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release , 1990, Journal of virology.
[35] H. Gendelman,et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.